Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disruption of bacterial cell membrane integrity is a well-established antimicrobial strategy that targets the unique structural and functional properties of bacterial membranes. This mechanism involves agents—often lipophilic or cationic molecules—that interact directly with the lipid bilayer, leading to loss of membrane architecture, increased permeability, depolarization, and ultimately cell death. The bacterial cell membrane is essential for maintaining ion gradients, energy production (via proton motive force), nutrient transport, and overall cellular homeostasis. Antimicrobial agents disrupt this integrity by inserting into or binding to the lipid bilayer, causing physical disruption such as pore formation or micelle-like structures, inducing leakage of cytoplasmic contents and rapid loss of ion gradients, and depolarizing the membrane potential required for ATP synthesis. Bacterial membranes are rich in negatively charged phospholipids compared to mammalian cells, allowing selective targeting by cationic antimicrobials. Agents like Daptomycin, Polymyxin B, and Oritavancin are examples of drugs that target bacterial membrane integrity. Resistance can develop via altered lipid composition, but the target remains a robust point for therapeutic intervention due to its essentiality and relative conservation.
Physical disruption: pore formation/depolarization/leakage
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Cell Membrane Integrity.